Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04777383Terminated
Open-label, single-arm trial of acetylcholine, norepinephrine, phenylephrine, atropine and neostigmine. Primary endpoint: Locally induced changes in red blood cell concentration and movement at 40 months. Started Apr 2019; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04777383.